Antimicrobial resistance is one of the greatest challenges facing modern medicine. A new class of programmable antibiotics known as asobiotics can be used to treat bacterial infections when classical antibiotics fail. A team of researchers from TWINCORE, Center for Experimental and Clinical Infection Research; the RESIST Cluster of Excellence; and the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg has now studied how bacteria adapt to asobiotics. They recently published their findings in Nature Communications.
Discover Recifes.net
This story is part of Recifes international coverage. Explore the platform and follow us — new English social channels come next.
